MED SCI MONITOR 润色咨询

MEDICAL SCIENCE MONITOR

出版年份:暂无数据 年文章数:6066 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:14.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=892175, encodeId=a5c48921e5f7, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:动脉硬化<br>经验分享:2500刀版面费。<br>2020-05-23 - Published<br>2020-03-28 - READY for publication<br>Note: Estimated Publication Date: May 24 - May 30, 2020<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Sent for prepublication antiplagiarism verification<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Proofread<br>2020-03-26 - Galley proof sent to authors<br>2020-03-16 - Sent for production<br>2020-03-16 - After copyediting<br>2020-03-15 - Waiting for authors decision after copyediting<br>2020-03-03 - In Copyediting<br>2020-03-03 - Paid<br>2020-03-02 - Accepted - invoice issued<br>2020-03-02 - After 1st post-review antiplagiarism verification<br>2020-03-02 - Sent for 1st post-review antiplagiarism verification<br>2020-03-02 - Ready for post-review antiplagiarism verification<br>2020-02-25 - Review 2 pending<br>2020-02-24 - Review 2 requests sent to reviewers<br>2020-02-23 - After authors corrections<br>2020-02-09 - Sent to author(s) for corrections (2 weeks)<br>2020-02-09 - Reconsider after revision<br>2020-02-07 - Awaiting decision<br>2020-02-07 - 2nd Scientific Triage Completed<br>2020-02-07 - In 2nd Scientific triage<br>2020-02-04 - Unlocked<br>2020-01-30 - Review pending<br>2020-01-30 - Evaluation requests sent to reviewers<br>2020-01-29 - After scientific triage<br>2020-01-29 - On hold<br>Note: Waiting for IRB translation.<br>2020-01-29 - In scientific triage<br>2020-01-29 - Manuscript accepted for processing<br>2020-01-29 - Manuscript CrossChecked<br>2020-01-29 - Sent for Plagiarism CrossCheck<br>2020-01-29 - Submission Approved<br>2020-01-29 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b642107106, createdName=阿桑v, createdTime=Thu Oct 15 09:07:26 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:医学<br>经验分享:一篇综述,从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见,有个六七条重复的,算大修吧,段落有调整,增加了部分内容和两个表格。逐条修改并回应审稿人,没用二次修改。共三次查重,投之前自己查了,修稿后自己也查了,所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591074, encodeId=a36a5910e45d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:看了这么多经验,中了也来回报一下大家。周期大致2个月左右。一般修稿感觉基本都有戏。 <br> 2020-05-06 - Accepted - invoice issued <br> 2020-05-06 - After 1st post-review antiplagiarism verification <br> 2020-05-06 - Sent for 1st post-review antiplagiarism verification <br> 2020-05-06 - Ready for post-review antiplagiarism verification <br> 2020-05-06 - Unlocked <br> Note: corrected <br> 2020-05-05 - On hold <br> Note: references should be in brackets [], and in line with the text [1] <br> 2020-05-05 - After authors corrections <br> 2020-04-20 - Sent to author for corrections (3 weeks) <br> 2020-04-20 - Reconsider after revision <br> 2020-04-19 - Awaiting decision <br> 2020-04-19 - 2nd Scientific Triage Completed <br> 2020-04-19 - In 2nd Scientific triage <br> 2020-04-01 - Review pending <br> 2020-03-17 - Evaluation requests sent to reviewers <br> 2020-03-01 - Unlocked <br> 2020-02-26 - Review pending <br> 2020-02-26 - Evaluation requests sent to reviewers <br> 2020-02-26 - On hold <br> Note: Waiting for IRB / IACUC <br> 2020-02-25 - After scientific triage <br> 2020-02-25 - In scientific triage <br> 2020-02-25 - Manuscript accepted for processing <br> 2020-02-25 - Manuscript CrossChecked <br> 2020-02-25 - Sent for Plagiarism CrossCheck <br> 2020-02-25 - Submission Approved <br> 2020-02-23 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24b12097035, createdName=1229603520_71901765, createdTime=Sun May 17 18:27:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903465, encodeId=3c0090346548, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:肿瘤临床研究;生物信息分析<br>经验分享:整体投稿,编辑处理,审稿效率超出我的预期,投稿到接收大概一个半月。<br><br>2020-11-29 - In Copyediting<br>2020-11-29 - Paid<br>2020-11-27 - Accepted - invoice issued<br>2020-11-27 - After 1st post-review antiplagiarism verification<br>2020-11-27 - Sent for 1st post-review antiplagiarism verification<br>2020-11-27 - Ready for post-review antiplagiarism verification<br>2020-11-26 - Review 2 pending<br>2020-11-26 - Review 2 requests sent to reviewers<br>2020-11-26 - After authors corrections<br>2020-11-13 - Sent to author(s) for corrections (2 weeks)<br>2020-11-13 - Reconsider after revision<br>2020-11-13 - Unlocked<br>Note: Personal review recived<br>2020-11-13 - Review pending<br>2020-11-12 - Evaluation requests sent to reviewers<br>2020-10-20 - Review pending<br>2020-10-20 - Evaluation requests sent to reviewers<br>2020-10-19 - After scientific triage<br>2020-10-19 - In scientific triage<br>2020-10-19 - Manuscript accepted for processing<br>2020-10-18 - After plagiarism verification 2<br>2020-10-18 - Sent for plagiarism verification 2<br>2020-10-17 - Man corrected after CrossCheck<br>2020-10-12 - CrossChecked - returned to authors for reply<br>2020-10-12 - Manuscript CrossChecked<br>2020-10-12 - Sent for Plagiarism CrossCheck<br>2020-10-12 - Submission Approved<br>2020-10-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/706d98e903d948364dfbf8450a2a19a2/53c01bd4b72a019dc1a06e2f2e3a7dc9.jpg, createdBy=26e72333435, createdName=12275916m01(暂无昵称), createdTime=Mon Nov 30 08:53:39 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960021, encodeId=2e1996002110, content=review pending后又变成Evaluation requests sent to reviewers 这是什么鬼??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Sat Apr 24 14:00:56 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800814, encodeId=d44b80081440, content=自己的第一篇投稿,mark一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Jul 01 20:19:28 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911882, encodeId=a43991188243, content=请问一下:我的文章在2020.11-19 t投稿,到现在还是review pending状态,请问怎么回事。我可以催稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/15/13ad315b99d85311e6569c41e7ed47b6.jpg, createdBy=43f42415702, createdName=liuweihansbraun_24757598, createdTime=Tue Dec 29 12:30:21 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905404, encodeId=215e9054046f, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:走的普通通道,临床回顾性文章,9月14日投稿,11月初修回,12月3日直接接收,还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a01905698, createdName=ms4149556704004813, createdTime=Sun Dec 06 14:15:27 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131403, encodeId=ab252131403b8, content=偏重的研究方向:综合<br>经验分享:2023-05-09 Evaluation requests sent to reviewers 2023-05-02 Review pending 2023-05-02 Evaluation requests sent to reviewers 2023-04-25 Review pending 2023-04-25 Evaluation requests sent to reviewers 2023-04-17 Review pending 2023-04-11 Evaluation requests sent to reviewers 为什么我一个月内送了四次(evaluation request to reviewers+review pending),是文章问题还是审稿人少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bfd5550012, createdName=ms2000001057542904, createdTime=Wed May 10 14:55:41 CST 2023, time=2023-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省)]
    2020-10-15 阿桑v

    审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2500.0
    偏重的研究方向:动脉硬化
    经验分享:2500刀版面费。
    2020-05-23 - Published
    2020-03-28 - READY for publication
    Note: Estimated Publication Date: May 24 - May 30, 2020
    2020-03-28 - Ready for prepublication antiplagiarism verification
    2020-03-28 - Sent for prepublication antiplagiarism verification
    2020-03-28 - Ready for prepublication antiplagiarism verification
    2020-03-28 - Proofread
    2020-03-26 - Galley proof sent to authors
    2020-03-16 - Sent for production
    2020-03-16 - After copyediting
    2020-03-15 - Waiting for authors decision after copyediting
    2020-03-03 - In Copyediting
    2020-03-03 - Paid
    2020-03-02 - Accepted - invoice issued
    2020-03-02 - After 1st post-review antiplagiarism verification
    2020-03-02 - Sent for 1st post-review antiplagiarism verification
    2020-03-02 - Ready for post-review antiplagiarism verification
    2020-02-25 - Review 2 pending
    2020-02-24 - Review 2 requests sent to reviewers
    2020-02-23 - After authors corrections
    2020-02-09 - Sent to author(s) for corrections (2 weeks)
    2020-02-09 - Reconsider after revision
    2020-02-07 - Awaiting decision
    2020-02-07 - 2nd Scientific Triage Completed
    2020-02-07 - In 2nd Scientific triage
    2020-02-04 - Unlocked
    2020-01-30 - Review pending
    2020-01-30 - Evaluation requests sent to reviewers
    2020-01-29 - After scientific triage
    2020-01-29 - On hold
    Note: Waiting for IRB translation.
    2020-01-29 - In scientific triage
    2020-01-29 - Manuscript accepted for processing
    2020-01-29 - Manuscript CrossChecked
    2020-01-29 - Sent for Plagiarism CrossCheck
    2020-01-29 - Submission Approved
    2020-01-29 - Submission Received

    5

    展开5条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=892175, encodeId=a5c48921e5f7, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:动脉硬化<br>经验分享:2500刀版面费。<br>2020-05-23 - Published<br>2020-03-28 - READY for publication<br>Note: Estimated Publication Date: May 24 - May 30, 2020<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Sent for prepublication antiplagiarism verification<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Proofread<br>2020-03-26 - Galley proof sent to authors<br>2020-03-16 - Sent for production<br>2020-03-16 - After copyediting<br>2020-03-15 - Waiting for authors decision after copyediting<br>2020-03-03 - In Copyediting<br>2020-03-03 - Paid<br>2020-03-02 - Accepted - invoice issued<br>2020-03-02 - After 1st post-review antiplagiarism verification<br>2020-03-02 - Sent for 1st post-review antiplagiarism verification<br>2020-03-02 - Ready for post-review antiplagiarism verification<br>2020-02-25 - Review 2 pending<br>2020-02-24 - Review 2 requests sent to reviewers<br>2020-02-23 - After authors corrections<br>2020-02-09 - Sent to author(s) for corrections (2 weeks)<br>2020-02-09 - Reconsider after revision<br>2020-02-07 - Awaiting decision<br>2020-02-07 - 2nd Scientific Triage Completed<br>2020-02-07 - In 2nd Scientific triage<br>2020-02-04 - Unlocked<br>2020-01-30 - Review pending<br>2020-01-30 - Evaluation requests sent to reviewers<br>2020-01-29 - After scientific triage<br>2020-01-29 - On hold<br>Note: Waiting for IRB translation.<br>2020-01-29 - In scientific triage<br>2020-01-29 - Manuscript accepted for processing<br>2020-01-29 - Manuscript CrossChecked<br>2020-01-29 - Sent for Plagiarism CrossCheck<br>2020-01-29 - Submission Approved<br>2020-01-29 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b642107106, createdName=阿桑v, createdTime=Thu Oct 15 09:07:26 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:医学<br>经验分享:一篇综述,从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见,有个六七条重复的,算大修吧,段落有调整,增加了部分内容和两个表格。逐条修改并回应审稿人,没用二次修改。共三次查重,投之前自己查了,修稿后自己也查了,所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591074, encodeId=a36a5910e45d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:看了这么多经验,中了也来回报一下大家。周期大致2个月左右。一般修稿感觉基本都有戏。 <br> 2020-05-06 - Accepted - invoice issued <br> 2020-05-06 - After 1st post-review antiplagiarism verification <br> 2020-05-06 - Sent for 1st post-review antiplagiarism verification <br> 2020-05-06 - Ready for post-review antiplagiarism verification <br> 2020-05-06 - Unlocked <br> Note: corrected <br> 2020-05-05 - On hold <br> Note: references should be in brackets [], and in line with the text [1] <br> 2020-05-05 - After authors corrections <br> 2020-04-20 - Sent to author for corrections (3 weeks) <br> 2020-04-20 - Reconsider after revision <br> 2020-04-19 - Awaiting decision <br> 2020-04-19 - 2nd Scientific Triage Completed <br> 2020-04-19 - In 2nd Scientific triage <br> 2020-04-01 - Review pending <br> 2020-03-17 - Evaluation requests sent to reviewers <br> 2020-03-01 - Unlocked <br> 2020-02-26 - Review pending <br> 2020-02-26 - Evaluation requests sent to reviewers <br> 2020-02-26 - On hold <br> Note: Waiting for IRB / IACUC <br> 2020-02-25 - After scientific triage <br> 2020-02-25 - In scientific triage <br> 2020-02-25 - Manuscript accepted for processing <br> 2020-02-25 - Manuscript CrossChecked <br> 2020-02-25 - Sent for Plagiarism CrossCheck <br> 2020-02-25 - Submission Approved <br> 2020-02-23 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24b12097035, createdName=1229603520_71901765, createdTime=Sun May 17 18:27:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903465, encodeId=3c0090346548, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:肿瘤临床研究;生物信息分析<br>经验分享:整体投稿,编辑处理,审稿效率超出我的预期,投稿到接收大概一个半月。<br><br>2020-11-29 - In Copyediting<br>2020-11-29 - Paid<br>2020-11-27 - Accepted - invoice issued<br>2020-11-27 - After 1st post-review antiplagiarism verification<br>2020-11-27 - Sent for 1st post-review antiplagiarism verification<br>2020-11-27 - Ready for post-review antiplagiarism verification<br>2020-11-26 - Review 2 pending<br>2020-11-26 - Review 2 requests sent to reviewers<br>2020-11-26 - After authors corrections<br>2020-11-13 - Sent to author(s) for corrections (2 weeks)<br>2020-11-13 - Reconsider after revision<br>2020-11-13 - Unlocked<br>Note: Personal review recived<br>2020-11-13 - Review pending<br>2020-11-12 - Evaluation requests sent to reviewers<br>2020-10-20 - Review pending<br>2020-10-20 - Evaluation requests sent to reviewers<br>2020-10-19 - After scientific triage<br>2020-10-19 - In scientific triage<br>2020-10-19 - Manuscript accepted for processing<br>2020-10-18 - After plagiarism verification 2<br>2020-10-18 - Sent for plagiarism verification 2<br>2020-10-17 - Man corrected after CrossCheck<br>2020-10-12 - CrossChecked - returned to authors for reply<br>2020-10-12 - Manuscript CrossChecked<br>2020-10-12 - Sent for Plagiarism CrossCheck<br>2020-10-12 - Submission Approved<br>2020-10-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/706d98e903d948364dfbf8450a2a19a2/53c01bd4b72a019dc1a06e2f2e3a7dc9.jpg, createdBy=26e72333435, createdName=12275916m01(暂无昵称), createdTime=Mon Nov 30 08:53:39 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960021, encodeId=2e1996002110, content=review pending后又变成Evaluation requests sent to reviewers 这是什么鬼??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Sat Apr 24 14:00:56 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800814, encodeId=d44b80081440, content=自己的第一篇投稿,mark一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Jul 01 20:19:28 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911882, encodeId=a43991188243, content=请问一下:我的文章在2020.11-19 t投稿,到现在还是review pending状态,请问怎么回事。我可以催稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/15/13ad315b99d85311e6569c41e7ed47b6.jpg, createdBy=43f42415702, createdName=liuweihansbraun_24757598, createdTime=Tue Dec 29 12:30:21 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905404, encodeId=215e9054046f, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:走的普通通道,临床回顾性文章,9月14日投稿,11月初修回,12月3日直接接收,还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a01905698, createdName=ms4149556704004813, createdTime=Sun Dec 06 14:15:27 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131403, encodeId=ab252131403b8, content=偏重的研究方向:综合<br>经验分享:2023-05-09 Evaluation requests sent to reviewers 2023-05-02 Review pending 2023-05-02 Evaluation requests sent to reviewers 2023-04-25 Review pending 2023-04-25 Evaluation requests sent to reviewers 2023-04-17 Review pending 2023-04-11 Evaluation requests sent to reviewers 为什么我一个月内送了四次(evaluation request to reviewers+review pending),是文章问题还是审稿人少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bfd5550012, createdName=ms2000001057542904, createdTime=Wed May 10 14:55:41 CST 2023, time=2023-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省)]
    2022-09-03 望洋兴叹0

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:医学
    经验分享:一篇综述,从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见,有个六七条重复的,算大修吧,段落有调整,增加了部分内容和两个表格。逐条修改并回应审稿人,没用二次修改。共三次查重,投之前自己查了,修稿后自己也查了,所以不涉及重复率高的问题。

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=892175, encodeId=a5c48921e5f7, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:动脉硬化<br>经验分享:2500刀版面费。<br>2020-05-23 - Published<br>2020-03-28 - READY for publication<br>Note: Estimated Publication Date: May 24 - May 30, 2020<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Sent for prepublication antiplagiarism verification<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Proofread<br>2020-03-26 - Galley proof sent to authors<br>2020-03-16 - Sent for production<br>2020-03-16 - After copyediting<br>2020-03-15 - Waiting for authors decision after copyediting<br>2020-03-03 - In Copyediting<br>2020-03-03 - Paid<br>2020-03-02 - Accepted - invoice issued<br>2020-03-02 - After 1st post-review antiplagiarism verification<br>2020-03-02 - Sent for 1st post-review antiplagiarism verification<br>2020-03-02 - Ready for post-review antiplagiarism verification<br>2020-02-25 - Review 2 pending<br>2020-02-24 - Review 2 requests sent to reviewers<br>2020-02-23 - After authors corrections<br>2020-02-09 - Sent to author(s) for corrections (2 weeks)<br>2020-02-09 - Reconsider after revision<br>2020-02-07 - Awaiting decision<br>2020-02-07 - 2nd Scientific Triage Completed<br>2020-02-07 - In 2nd Scientific triage<br>2020-02-04 - Unlocked<br>2020-01-30 - Review pending<br>2020-01-30 - Evaluation requests sent to reviewers<br>2020-01-29 - After scientific triage<br>2020-01-29 - On hold<br>Note: Waiting for IRB translation.<br>2020-01-29 - In scientific triage<br>2020-01-29 - Manuscript accepted for processing<br>2020-01-29 - Manuscript CrossChecked<br>2020-01-29 - Sent for Plagiarism CrossCheck<br>2020-01-29 - Submission Approved<br>2020-01-29 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b642107106, createdName=阿桑v, createdTime=Thu Oct 15 09:07:26 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:医学<br>经验分享:一篇综述,从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见,有个六七条重复的,算大修吧,段落有调整,增加了部分内容和两个表格。逐条修改并回应审稿人,没用二次修改。共三次查重,投之前自己查了,修稿后自己也查了,所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591074, encodeId=a36a5910e45d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:看了这么多经验,中了也来回报一下大家。周期大致2个月左右。一般修稿感觉基本都有戏。 <br> 2020-05-06 - Accepted - invoice issued <br> 2020-05-06 - After 1st post-review antiplagiarism verification <br> 2020-05-06 - Sent for 1st post-review antiplagiarism verification <br> 2020-05-06 - Ready for post-review antiplagiarism verification <br> 2020-05-06 - Unlocked <br> Note: corrected <br> 2020-05-05 - On hold <br> Note: references should be in brackets [], and in line with the text [1] <br> 2020-05-05 - After authors corrections <br> 2020-04-20 - Sent to author for corrections (3 weeks) <br> 2020-04-20 - Reconsider after revision <br> 2020-04-19 - Awaiting decision <br> 2020-04-19 - 2nd Scientific Triage Completed <br> 2020-04-19 - In 2nd Scientific triage <br> 2020-04-01 - Review pending <br> 2020-03-17 - Evaluation requests sent to reviewers <br> 2020-03-01 - Unlocked <br> 2020-02-26 - Review pending <br> 2020-02-26 - Evaluation requests sent to reviewers <br> 2020-02-26 - On hold <br> Note: Waiting for IRB / IACUC <br> 2020-02-25 - After scientific triage <br> 2020-02-25 - In scientific triage <br> 2020-02-25 - Manuscript accepted for processing <br> 2020-02-25 - Manuscript CrossChecked <br> 2020-02-25 - Sent for Plagiarism CrossCheck <br> 2020-02-25 - Submission Approved <br> 2020-02-23 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24b12097035, createdName=1229603520_71901765, createdTime=Sun May 17 18:27:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903465, encodeId=3c0090346548, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:肿瘤临床研究;生物信息分析<br>经验分享:整体投稿,编辑处理,审稿效率超出我的预期,投稿到接收大概一个半月。<br><br>2020-11-29 - In Copyediting<br>2020-11-29 - Paid<br>2020-11-27 - Accepted - invoice issued<br>2020-11-27 - After 1st post-review antiplagiarism verification<br>2020-11-27 - Sent for 1st post-review antiplagiarism verification<br>2020-11-27 - Ready for post-review antiplagiarism verification<br>2020-11-26 - Review 2 pending<br>2020-11-26 - Review 2 requests sent to reviewers<br>2020-11-26 - After authors corrections<br>2020-11-13 - Sent to author(s) for corrections (2 weeks)<br>2020-11-13 - Reconsider after revision<br>2020-11-13 - Unlocked<br>Note: Personal review recived<br>2020-11-13 - Review pending<br>2020-11-12 - Evaluation requests sent to reviewers<br>2020-10-20 - Review pending<br>2020-10-20 - Evaluation requests sent to reviewers<br>2020-10-19 - After scientific triage<br>2020-10-19 - In scientific triage<br>2020-10-19 - Manuscript accepted for processing<br>2020-10-18 - After plagiarism verification 2<br>2020-10-18 - Sent for plagiarism verification 2<br>2020-10-17 - Man corrected after CrossCheck<br>2020-10-12 - CrossChecked - returned to authors for reply<br>2020-10-12 - Manuscript CrossChecked<br>2020-10-12 - Sent for Plagiarism CrossCheck<br>2020-10-12 - Submission Approved<br>2020-10-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/706d98e903d948364dfbf8450a2a19a2/53c01bd4b72a019dc1a06e2f2e3a7dc9.jpg, createdBy=26e72333435, createdName=12275916m01(暂无昵称), createdTime=Mon Nov 30 08:53:39 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960021, encodeId=2e1996002110, content=review pending后又变成Evaluation requests sent to reviewers 这是什么鬼??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Sat Apr 24 14:00:56 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800814, encodeId=d44b80081440, content=自己的第一篇投稿,mark一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Jul 01 20:19:28 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911882, encodeId=a43991188243, content=请问一下:我的文章在2020.11-19 t投稿,到现在还是review pending状态,请问怎么回事。我可以催稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/15/13ad315b99d85311e6569c41e7ed47b6.jpg, createdBy=43f42415702, createdName=liuweihansbraun_24757598, createdTime=Tue Dec 29 12:30:21 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905404, encodeId=215e9054046f, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:走的普通通道,临床回顾性文章,9月14日投稿,11月初修回,12月3日直接接收,还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a01905698, createdName=ms4149556704004813, createdTime=Sun Dec 06 14:15:27 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131403, encodeId=ab252131403b8, content=偏重的研究方向:综合<br>经验分享:2023-05-09 Evaluation requests sent to reviewers 2023-05-02 Review pending 2023-05-02 Evaluation requests sent to reviewers 2023-04-25 Review pending 2023-04-25 Evaluation requests sent to reviewers 2023-04-17 Review pending 2023-04-11 Evaluation requests sent to reviewers 为什么我一个月内送了四次(evaluation request to reviewers+review pending),是文章问题还是审稿人少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bfd5550012, createdName=ms2000001057542904, createdTime=Wed May 10 14:55:41 CST 2023, time=2023-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省)]
    2020-05-17 1229603520_71901765

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:看了这么多经验,中了也来回报一下大家。周期大致2个月左右。一般修稿感觉基本都有戏。
    2020-05-06 - Accepted - invoice issued
    2020-05-06 - After 1st post-review antiplagiarism verification
    2020-05-06 - Sent for 1st post-review antiplagiarism verification
    2020-05-06 - Ready for post-review antiplagiarism verification
    2020-05-06 - Unlocked
    Note: corrected
    2020-05-05 - On hold
    Note: references should be in brackets [], and in line with the text [1]
    2020-05-05 - After authors corrections
    2020-04-20 - Sent to author for corrections (3 weeks)
    2020-04-20 - Reconsider after revision
    2020-04-19 - Awaiting decision
    2020-04-19 - 2nd Scientific Triage Completed
    2020-04-19 - In 2nd Scientific triage
    2020-04-01 - Review pending
    2020-03-17 - Evaluation requests sent to reviewers
    2020-03-01 - Unlocked
    2020-02-26 - Review pending
    2020-02-26 - Evaluation requests sent to reviewers
    2020-02-26 - On hold
    Note: Waiting for IRB / IACUC
    2020-02-25 - After scientific triage
    2020-02-25 - In scientific triage
    2020-02-25 - Manuscript accepted for processing
    2020-02-25 - Manuscript CrossChecked
    2020-02-25 - Sent for Plagiarism CrossCheck
    2020-02-25 - Submission Approved
    2020-02-23 - Submission Received

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=892175, encodeId=a5c48921e5f7, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:动脉硬化<br>经验分享:2500刀版面费。<br>2020-05-23 - Published<br>2020-03-28 - READY for publication<br>Note: Estimated Publication Date: May 24 - May 30, 2020<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Sent for prepublication antiplagiarism verification<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Proofread<br>2020-03-26 - Galley proof sent to authors<br>2020-03-16 - Sent for production<br>2020-03-16 - After copyediting<br>2020-03-15 - Waiting for authors decision after copyediting<br>2020-03-03 - In Copyediting<br>2020-03-03 - Paid<br>2020-03-02 - Accepted - invoice issued<br>2020-03-02 - After 1st post-review antiplagiarism verification<br>2020-03-02 - Sent for 1st post-review antiplagiarism verification<br>2020-03-02 - Ready for post-review antiplagiarism verification<br>2020-02-25 - Review 2 pending<br>2020-02-24 - Review 2 requests sent to reviewers<br>2020-02-23 - After authors corrections<br>2020-02-09 - Sent to author(s) for corrections (2 weeks)<br>2020-02-09 - Reconsider after revision<br>2020-02-07 - Awaiting decision<br>2020-02-07 - 2nd Scientific Triage Completed<br>2020-02-07 - In 2nd Scientific triage<br>2020-02-04 - Unlocked<br>2020-01-30 - Review pending<br>2020-01-30 - Evaluation requests sent to reviewers<br>2020-01-29 - After scientific triage<br>2020-01-29 - On hold<br>Note: Waiting for IRB translation.<br>2020-01-29 - In scientific triage<br>2020-01-29 - Manuscript accepted for processing<br>2020-01-29 - Manuscript CrossChecked<br>2020-01-29 - Sent for Plagiarism CrossCheck<br>2020-01-29 - Submission Approved<br>2020-01-29 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b642107106, createdName=阿桑v, createdTime=Thu Oct 15 09:07:26 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:医学<br>经验分享:一篇综述,从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见,有个六七条重复的,算大修吧,段落有调整,增加了部分内容和两个表格。逐条修改并回应审稿人,没用二次修改。共三次查重,投之前自己查了,修稿后自己也查了,所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591074, encodeId=a36a5910e45d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:看了这么多经验,中了也来回报一下大家。周期大致2个月左右。一般修稿感觉基本都有戏。 <br> 2020-05-06 - Accepted - invoice issued <br> 2020-05-06 - After 1st post-review antiplagiarism verification <br> 2020-05-06 - Sent for 1st post-review antiplagiarism verification <br> 2020-05-06 - Ready for post-review antiplagiarism verification <br> 2020-05-06 - Unlocked <br> Note: corrected <br> 2020-05-05 - On hold <br> Note: references should be in brackets [], and in line with the text [1] <br> 2020-05-05 - After authors corrections <br> 2020-04-20 - Sent to author for corrections (3 weeks) <br> 2020-04-20 - Reconsider after revision <br> 2020-04-19 - Awaiting decision <br> 2020-04-19 - 2nd Scientific Triage Completed <br> 2020-04-19 - In 2nd Scientific triage <br> 2020-04-01 - Review pending <br> 2020-03-17 - Evaluation requests sent to reviewers <br> 2020-03-01 - Unlocked <br> 2020-02-26 - Review pending <br> 2020-02-26 - Evaluation requests sent to reviewers <br> 2020-02-26 - On hold <br> Note: Waiting for IRB / IACUC <br> 2020-02-25 - After scientific triage <br> 2020-02-25 - In scientific triage <br> 2020-02-25 - Manuscript accepted for processing <br> 2020-02-25 - Manuscript CrossChecked <br> 2020-02-25 - Sent for Plagiarism CrossCheck <br> 2020-02-25 - Submission Approved <br> 2020-02-23 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24b12097035, createdName=1229603520_71901765, createdTime=Sun May 17 18:27:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903465, encodeId=3c0090346548, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:肿瘤临床研究;生物信息分析<br>经验分享:整体投稿,编辑处理,审稿效率超出我的预期,投稿到接收大概一个半月。<br><br>2020-11-29 - In Copyediting<br>2020-11-29 - Paid<br>2020-11-27 - Accepted - invoice issued<br>2020-11-27 - After 1st post-review antiplagiarism verification<br>2020-11-27 - Sent for 1st post-review antiplagiarism verification<br>2020-11-27 - Ready for post-review antiplagiarism verification<br>2020-11-26 - Review 2 pending<br>2020-11-26 - Review 2 requests sent to reviewers<br>2020-11-26 - After authors corrections<br>2020-11-13 - Sent to author(s) for corrections (2 weeks)<br>2020-11-13 - Reconsider after revision<br>2020-11-13 - Unlocked<br>Note: Personal review recived<br>2020-11-13 - Review pending<br>2020-11-12 - Evaluation requests sent to reviewers<br>2020-10-20 - Review pending<br>2020-10-20 - Evaluation requests sent to reviewers<br>2020-10-19 - After scientific triage<br>2020-10-19 - In scientific triage<br>2020-10-19 - Manuscript accepted for processing<br>2020-10-18 - After plagiarism verification 2<br>2020-10-18 - Sent for plagiarism verification 2<br>2020-10-17 - Man corrected after CrossCheck<br>2020-10-12 - CrossChecked - returned to authors for reply<br>2020-10-12 - Manuscript CrossChecked<br>2020-10-12 - Sent for Plagiarism CrossCheck<br>2020-10-12 - Submission Approved<br>2020-10-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/706d98e903d948364dfbf8450a2a19a2/53c01bd4b72a019dc1a06e2f2e3a7dc9.jpg, createdBy=26e72333435, createdName=12275916m01(暂无昵称), createdTime=Mon Nov 30 08:53:39 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960021, encodeId=2e1996002110, content=review pending后又变成Evaluation requests sent to reviewers 这是什么鬼??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Sat Apr 24 14:00:56 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800814, encodeId=d44b80081440, content=自己的第一篇投稿,mark一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Jul 01 20:19:28 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911882, encodeId=a43991188243, content=请问一下:我的文章在2020.11-19 t投稿,到现在还是review pending状态,请问怎么回事。我可以催稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/15/13ad315b99d85311e6569c41e7ed47b6.jpg, createdBy=43f42415702, createdName=liuweihansbraun_24757598, createdTime=Tue Dec 29 12:30:21 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905404, encodeId=215e9054046f, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:走的普通通道,临床回顾性文章,9月14日投稿,11月初修回,12月3日直接接收,还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a01905698, createdName=ms4149556704004813, createdTime=Sun Dec 06 14:15:27 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131403, encodeId=ab252131403b8, content=偏重的研究方向:综合<br>经验分享:2023-05-09 Evaluation requests sent to reviewers 2023-05-02 Review pending 2023-05-02 Evaluation requests sent to reviewers 2023-04-25 Review pending 2023-04-25 Evaluation requests sent to reviewers 2023-04-17 Review pending 2023-04-11 Evaluation requests sent to reviewers 为什么我一个月内送了四次(evaluation request to reviewers+review pending),是文章问题还是审稿人少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bfd5550012, createdName=ms2000001057542904, createdTime=Wed May 10 14:55:41 CST 2023, time=2023-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省)]
    2020-11-30 12275916m01(暂无昵称)

    审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0
    偏重的研究方向:肿瘤临床研究;生物信息分析
    经验分享:整体投稿,编辑处理,审稿效率超出我的预期,投稿到接收大概一个半月。

    2020-11-29 - In Copyediting
    2020-11-29 - Paid
    2020-11-27 - Accepted - invoice issued
    2020-11-27 - After 1st post-review antiplagiarism verification
    2020-11-27 - Sent for 1st post-review antiplagiarism verification
    2020-11-27 - Ready for post-review antiplagiarism verification
    2020-11-26 - Review 2 pending
    2020-11-26 - Review 2 requests sent to reviewers
    2020-11-26 - After authors corrections
    2020-11-13 - Sent to author(s) for corrections (2 weeks)
    2020-11-13 - Reconsider after revision
    2020-11-13 - Unlocked
    Note: Personal review recived
    2020-11-13 - Review pending
    2020-11-12 - Evaluation requests sent to reviewers
    2020-10-20 - Review pending
    2020-10-20 - Evaluation requests sent to reviewers
    2020-10-19 - After scientific triage
    2020-10-19 - In scientific triage
    2020-10-19 - Manuscript accepted for processing
    2020-10-18 - After plagiarism verification 2
    2020-10-18 - Sent for plagiarism verification 2
    2020-10-17 - Man corrected after CrossCheck
    2020-10-12 - CrossChecked - returned to authors for reply
    2020-10-12 - Manuscript CrossChecked
    2020-10-12 - Sent for Plagiarism CrossCheck
    2020-10-12 - Submission Approved
    2020-10-11 - Submission Received

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=892175, encodeId=a5c48921e5f7, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:动脉硬化<br>经验分享:2500刀版面费。<br>2020-05-23 - Published<br>2020-03-28 - READY for publication<br>Note: Estimated Publication Date: May 24 - May 30, 2020<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Sent for prepublication antiplagiarism verification<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Proofread<br>2020-03-26 - Galley proof sent to authors<br>2020-03-16 - Sent for production<br>2020-03-16 - After copyediting<br>2020-03-15 - Waiting for authors decision after copyediting<br>2020-03-03 - In Copyediting<br>2020-03-03 - Paid<br>2020-03-02 - Accepted - invoice issued<br>2020-03-02 - After 1st post-review antiplagiarism verification<br>2020-03-02 - Sent for 1st post-review antiplagiarism verification<br>2020-03-02 - Ready for post-review antiplagiarism verification<br>2020-02-25 - Review 2 pending<br>2020-02-24 - Review 2 requests sent to reviewers<br>2020-02-23 - After authors corrections<br>2020-02-09 - Sent to author(s) for corrections (2 weeks)<br>2020-02-09 - Reconsider after revision<br>2020-02-07 - Awaiting decision<br>2020-02-07 - 2nd Scientific Triage Completed<br>2020-02-07 - In 2nd Scientific triage<br>2020-02-04 - Unlocked<br>2020-01-30 - Review pending<br>2020-01-30 - Evaluation requests sent to reviewers<br>2020-01-29 - After scientific triage<br>2020-01-29 - On hold<br>Note: Waiting for IRB translation.<br>2020-01-29 - In scientific triage<br>2020-01-29 - Manuscript accepted for processing<br>2020-01-29 - Manuscript CrossChecked<br>2020-01-29 - Sent for Plagiarism CrossCheck<br>2020-01-29 - Submission Approved<br>2020-01-29 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b642107106, createdName=阿桑v, createdTime=Thu Oct 15 09:07:26 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:医学<br>经验分享:一篇综述,从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见,有个六七条重复的,算大修吧,段落有调整,增加了部分内容和两个表格。逐条修改并回应审稿人,没用二次修改。共三次查重,投之前自己查了,修稿后自己也查了,所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591074, encodeId=a36a5910e45d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:看了这么多经验,中了也来回报一下大家。周期大致2个月左右。一般修稿感觉基本都有戏。 <br> 2020-05-06 - Accepted - invoice issued <br> 2020-05-06 - After 1st post-review antiplagiarism verification <br> 2020-05-06 - Sent for 1st post-review antiplagiarism verification <br> 2020-05-06 - Ready for post-review antiplagiarism verification <br> 2020-05-06 - Unlocked <br> Note: corrected <br> 2020-05-05 - On hold <br> Note: references should be in brackets [], and in line with the text [1] <br> 2020-05-05 - After authors corrections <br> 2020-04-20 - Sent to author for corrections (3 weeks) <br> 2020-04-20 - Reconsider after revision <br> 2020-04-19 - Awaiting decision <br> 2020-04-19 - 2nd Scientific Triage Completed <br> 2020-04-19 - In 2nd Scientific triage <br> 2020-04-01 - Review pending <br> 2020-03-17 - Evaluation requests sent to reviewers <br> 2020-03-01 - Unlocked <br> 2020-02-26 - Review pending <br> 2020-02-26 - Evaluation requests sent to reviewers <br> 2020-02-26 - On hold <br> Note: Waiting for IRB / IACUC <br> 2020-02-25 - After scientific triage <br> 2020-02-25 - In scientific triage <br> 2020-02-25 - Manuscript accepted for processing <br> 2020-02-25 - Manuscript CrossChecked <br> 2020-02-25 - Sent for Plagiarism CrossCheck <br> 2020-02-25 - Submission Approved <br> 2020-02-23 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24b12097035, createdName=1229603520_71901765, createdTime=Sun May 17 18:27:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903465, encodeId=3c0090346548, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:肿瘤临床研究;生物信息分析<br>经验分享:整体投稿,编辑处理,审稿效率超出我的预期,投稿到接收大概一个半月。<br><br>2020-11-29 - In Copyediting<br>2020-11-29 - Paid<br>2020-11-27 - Accepted - invoice issued<br>2020-11-27 - After 1st post-review antiplagiarism verification<br>2020-11-27 - Sent for 1st post-review antiplagiarism verification<br>2020-11-27 - Ready for post-review antiplagiarism verification<br>2020-11-26 - Review 2 pending<br>2020-11-26 - Review 2 requests sent to reviewers<br>2020-11-26 - After authors corrections<br>2020-11-13 - Sent to author(s) for corrections (2 weeks)<br>2020-11-13 - Reconsider after revision<br>2020-11-13 - Unlocked<br>Note: Personal review recived<br>2020-11-13 - Review pending<br>2020-11-12 - Evaluation requests sent to reviewers<br>2020-10-20 - Review pending<br>2020-10-20 - Evaluation requests sent to reviewers<br>2020-10-19 - After scientific triage<br>2020-10-19 - In scientific triage<br>2020-10-19 - Manuscript accepted for processing<br>2020-10-18 - After plagiarism verification 2<br>2020-10-18 - Sent for plagiarism verification 2<br>2020-10-17 - Man corrected after CrossCheck<br>2020-10-12 - CrossChecked - returned to authors for reply<br>2020-10-12 - Manuscript CrossChecked<br>2020-10-12 - Sent for Plagiarism CrossCheck<br>2020-10-12 - Submission Approved<br>2020-10-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/706d98e903d948364dfbf8450a2a19a2/53c01bd4b72a019dc1a06e2f2e3a7dc9.jpg, createdBy=26e72333435, createdName=12275916m01(暂无昵称), createdTime=Mon Nov 30 08:53:39 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960021, encodeId=2e1996002110, content=review pending后又变成Evaluation requests sent to reviewers 这是什么鬼??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Sat Apr 24 14:00:56 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800814, encodeId=d44b80081440, content=自己的第一篇投稿,mark一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Jul 01 20:19:28 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911882, encodeId=a43991188243, content=请问一下:我的文章在2020.11-19 t投稿,到现在还是review pending状态,请问怎么回事。我可以催稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/15/13ad315b99d85311e6569c41e7ed47b6.jpg, createdBy=43f42415702, createdName=liuweihansbraun_24757598, createdTime=Tue Dec 29 12:30:21 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905404, encodeId=215e9054046f, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:走的普通通道,临床回顾性文章,9月14日投稿,11月初修回,12月3日直接接收,还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a01905698, createdName=ms4149556704004813, createdTime=Sun Dec 06 14:15:27 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131403, encodeId=ab252131403b8, content=偏重的研究方向:综合<br>经验分享:2023-05-09 Evaluation requests sent to reviewers 2023-05-02 Review pending 2023-05-02 Evaluation requests sent to reviewers 2023-04-25 Review pending 2023-04-25 Evaluation requests sent to reviewers 2023-04-17 Review pending 2023-04-11 Evaluation requests sent to reviewers 为什么我一个月内送了四次(evaluation request to reviewers+review pending),是文章问题还是审稿人少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bfd5550012, createdName=ms2000001057542904, createdTime=Wed May 10 14:55:41 CST 2023, time=2023-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省)]
    2021-04-24 ms1000000289565013

    review pending后又变成Evaluation requests sent to reviewers 这是什么鬼??

    4

    展开4条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=892175, encodeId=a5c48921e5f7, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:动脉硬化<br>经验分享:2500刀版面费。<br>2020-05-23 - Published<br>2020-03-28 - READY for publication<br>Note: Estimated Publication Date: May 24 - May 30, 2020<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Sent for prepublication antiplagiarism verification<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Proofread<br>2020-03-26 - Galley proof sent to authors<br>2020-03-16 - Sent for production<br>2020-03-16 - After copyediting<br>2020-03-15 - Waiting for authors decision after copyediting<br>2020-03-03 - In Copyediting<br>2020-03-03 - Paid<br>2020-03-02 - Accepted - invoice issued<br>2020-03-02 - After 1st post-review antiplagiarism verification<br>2020-03-02 - Sent for 1st post-review antiplagiarism verification<br>2020-03-02 - Ready for post-review antiplagiarism verification<br>2020-02-25 - Review 2 pending<br>2020-02-24 - Review 2 requests sent to reviewers<br>2020-02-23 - After authors corrections<br>2020-02-09 - Sent to author(s) for corrections (2 weeks)<br>2020-02-09 - Reconsider after revision<br>2020-02-07 - Awaiting decision<br>2020-02-07 - 2nd Scientific Triage Completed<br>2020-02-07 - In 2nd Scientific triage<br>2020-02-04 - Unlocked<br>2020-01-30 - Review pending<br>2020-01-30 - Evaluation requests sent to reviewers<br>2020-01-29 - After scientific triage<br>2020-01-29 - On hold<br>Note: Waiting for IRB translation.<br>2020-01-29 - In scientific triage<br>2020-01-29 - Manuscript accepted for processing<br>2020-01-29 - Manuscript CrossChecked<br>2020-01-29 - Sent for Plagiarism CrossCheck<br>2020-01-29 - Submission Approved<br>2020-01-29 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b642107106, createdName=阿桑v, createdTime=Thu Oct 15 09:07:26 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:医学<br>经验分享:一篇综述,从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见,有个六七条重复的,算大修吧,段落有调整,增加了部分内容和两个表格。逐条修改并回应审稿人,没用二次修改。共三次查重,投之前自己查了,修稿后自己也查了,所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591074, encodeId=a36a5910e45d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:看了这么多经验,中了也来回报一下大家。周期大致2个月左右。一般修稿感觉基本都有戏。 <br> 2020-05-06 - Accepted - invoice issued <br> 2020-05-06 - After 1st post-review antiplagiarism verification <br> 2020-05-06 - Sent for 1st post-review antiplagiarism verification <br> 2020-05-06 - Ready for post-review antiplagiarism verification <br> 2020-05-06 - Unlocked <br> Note: corrected <br> 2020-05-05 - On hold <br> Note: references should be in brackets [], and in line with the text [1] <br> 2020-05-05 - After authors corrections <br> 2020-04-20 - Sent to author for corrections (3 weeks) <br> 2020-04-20 - Reconsider after revision <br> 2020-04-19 - Awaiting decision <br> 2020-04-19 - 2nd Scientific Triage Completed <br> 2020-04-19 - In 2nd Scientific triage <br> 2020-04-01 - Review pending <br> 2020-03-17 - Evaluation requests sent to reviewers <br> 2020-03-01 - Unlocked <br> 2020-02-26 - Review pending <br> 2020-02-26 - Evaluation requests sent to reviewers <br> 2020-02-26 - On hold <br> Note: Waiting for IRB / IACUC <br> 2020-02-25 - After scientific triage <br> 2020-02-25 - In scientific triage <br> 2020-02-25 - Manuscript accepted for processing <br> 2020-02-25 - Manuscript CrossChecked <br> 2020-02-25 - Sent for Plagiarism CrossCheck <br> 2020-02-25 - Submission Approved <br> 2020-02-23 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24b12097035, createdName=1229603520_71901765, createdTime=Sun May 17 18:27:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903465, encodeId=3c0090346548, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:肿瘤临床研究;生物信息分析<br>经验分享:整体投稿,编辑处理,审稿效率超出我的预期,投稿到接收大概一个半月。<br><br>2020-11-29 - In Copyediting<br>2020-11-29 - Paid<br>2020-11-27 - Accepted - invoice issued<br>2020-11-27 - After 1st post-review antiplagiarism verification<br>2020-11-27 - Sent for 1st post-review antiplagiarism verification<br>2020-11-27 - Ready for post-review antiplagiarism verification<br>2020-11-26 - Review 2 pending<br>2020-11-26 - Review 2 requests sent to reviewers<br>2020-11-26 - After authors corrections<br>2020-11-13 - Sent to author(s) for corrections (2 weeks)<br>2020-11-13 - Reconsider after revision<br>2020-11-13 - Unlocked<br>Note: Personal review recived<br>2020-11-13 - Review pending<br>2020-11-12 - Evaluation requests sent to reviewers<br>2020-10-20 - Review pending<br>2020-10-20 - Evaluation requests sent to reviewers<br>2020-10-19 - After scientific triage<br>2020-10-19 - In scientific triage<br>2020-10-19 - Manuscript accepted for processing<br>2020-10-18 - After plagiarism verification 2<br>2020-10-18 - Sent for plagiarism verification 2<br>2020-10-17 - Man corrected after CrossCheck<br>2020-10-12 - CrossChecked - returned to authors for reply<br>2020-10-12 - Manuscript CrossChecked<br>2020-10-12 - Sent for Plagiarism CrossCheck<br>2020-10-12 - Submission Approved<br>2020-10-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/706d98e903d948364dfbf8450a2a19a2/53c01bd4b72a019dc1a06e2f2e3a7dc9.jpg, createdBy=26e72333435, createdName=12275916m01(暂无昵称), createdTime=Mon Nov 30 08:53:39 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960021, encodeId=2e1996002110, content=review pending后又变成Evaluation requests sent to reviewers 这是什么鬼??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Sat Apr 24 14:00:56 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800814, encodeId=d44b80081440, content=自己的第一篇投稿,mark一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Jul 01 20:19:28 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911882, encodeId=a43991188243, content=请问一下:我的文章在2020.11-19 t投稿,到现在还是review pending状态,请问怎么回事。我可以催稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/15/13ad315b99d85311e6569c41e7ed47b6.jpg, createdBy=43f42415702, createdName=liuweihansbraun_24757598, createdTime=Tue Dec 29 12:30:21 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905404, encodeId=215e9054046f, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:走的普通通道,临床回顾性文章,9月14日投稿,11月初修回,12月3日直接接收,还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a01905698, createdName=ms4149556704004813, createdTime=Sun Dec 06 14:15:27 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131403, encodeId=ab252131403b8, content=偏重的研究方向:综合<br>经验分享:2023-05-09 Evaluation requests sent to reviewers 2023-05-02 Review pending 2023-05-02 Evaluation requests sent to reviewers 2023-04-25 Review pending 2023-04-25 Evaluation requests sent to reviewers 2023-04-17 Review pending 2023-04-11 Evaluation requests sent to reviewers 为什么我一个月内送了四次(evaluation request to reviewers+review pending),是文章问题还是审稿人少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bfd5550012, createdName=ms2000001057542904, createdTime=Wed May 10 14:55:41 CST 2023, time=2023-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省)]
    2020-07-01 starter2009

    自己的第一篇投稿,mark一下

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=892175, encodeId=a5c48921e5f7, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:动脉硬化<br>经验分享:2500刀版面费。<br>2020-05-23 - Published<br>2020-03-28 - READY for publication<br>Note: Estimated Publication Date: May 24 - May 30, 2020<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Sent for prepublication antiplagiarism verification<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Proofread<br>2020-03-26 - Galley proof sent to authors<br>2020-03-16 - Sent for production<br>2020-03-16 - After copyediting<br>2020-03-15 - Waiting for authors decision after copyediting<br>2020-03-03 - In Copyediting<br>2020-03-03 - Paid<br>2020-03-02 - Accepted - invoice issued<br>2020-03-02 - After 1st post-review antiplagiarism verification<br>2020-03-02 - Sent for 1st post-review antiplagiarism verification<br>2020-03-02 - Ready for post-review antiplagiarism verification<br>2020-02-25 - Review 2 pending<br>2020-02-24 - Review 2 requests sent to reviewers<br>2020-02-23 - After authors corrections<br>2020-02-09 - Sent to author(s) for corrections (2 weeks)<br>2020-02-09 - Reconsider after revision<br>2020-02-07 - Awaiting decision<br>2020-02-07 - 2nd Scientific Triage Completed<br>2020-02-07 - In 2nd Scientific triage<br>2020-02-04 - Unlocked<br>2020-01-30 - Review pending<br>2020-01-30 - Evaluation requests sent to reviewers<br>2020-01-29 - After scientific triage<br>2020-01-29 - On hold<br>Note: Waiting for IRB translation.<br>2020-01-29 - In scientific triage<br>2020-01-29 - Manuscript accepted for processing<br>2020-01-29 - Manuscript CrossChecked<br>2020-01-29 - Sent for Plagiarism CrossCheck<br>2020-01-29 - Submission Approved<br>2020-01-29 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b642107106, createdName=阿桑v, createdTime=Thu Oct 15 09:07:26 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:医学<br>经验分享:一篇综述,从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见,有个六七条重复的,算大修吧,段落有调整,增加了部分内容和两个表格。逐条修改并回应审稿人,没用二次修改。共三次查重,投之前自己查了,修稿后自己也查了,所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591074, encodeId=a36a5910e45d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:看了这么多经验,中了也来回报一下大家。周期大致2个月左右。一般修稿感觉基本都有戏。 <br> 2020-05-06 - Accepted - invoice issued <br> 2020-05-06 - After 1st post-review antiplagiarism verification <br> 2020-05-06 - Sent for 1st post-review antiplagiarism verification <br> 2020-05-06 - Ready for post-review antiplagiarism verification <br> 2020-05-06 - Unlocked <br> Note: corrected <br> 2020-05-05 - On hold <br> Note: references should be in brackets [], and in line with the text [1] <br> 2020-05-05 - After authors corrections <br> 2020-04-20 - Sent to author for corrections (3 weeks) <br> 2020-04-20 - Reconsider after revision <br> 2020-04-19 - Awaiting decision <br> 2020-04-19 - 2nd Scientific Triage Completed <br> 2020-04-19 - In 2nd Scientific triage <br> 2020-04-01 - Review pending <br> 2020-03-17 - Evaluation requests sent to reviewers <br> 2020-03-01 - Unlocked <br> 2020-02-26 - Review pending <br> 2020-02-26 - Evaluation requests sent to reviewers <br> 2020-02-26 - On hold <br> Note: Waiting for IRB / IACUC <br> 2020-02-25 - After scientific triage <br> 2020-02-25 - In scientific triage <br> 2020-02-25 - Manuscript accepted for processing <br> 2020-02-25 - Manuscript CrossChecked <br> 2020-02-25 - Sent for Plagiarism CrossCheck <br> 2020-02-25 - Submission Approved <br> 2020-02-23 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24b12097035, createdName=1229603520_71901765, createdTime=Sun May 17 18:27:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903465, encodeId=3c0090346548, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:肿瘤临床研究;生物信息分析<br>经验分享:整体投稿,编辑处理,审稿效率超出我的预期,投稿到接收大概一个半月。<br><br>2020-11-29 - In Copyediting<br>2020-11-29 - Paid<br>2020-11-27 - Accepted - invoice issued<br>2020-11-27 - After 1st post-review antiplagiarism verification<br>2020-11-27 - Sent for 1st post-review antiplagiarism verification<br>2020-11-27 - Ready for post-review antiplagiarism verification<br>2020-11-26 - Review 2 pending<br>2020-11-26 - Review 2 requests sent to reviewers<br>2020-11-26 - After authors corrections<br>2020-11-13 - Sent to author(s) for corrections (2 weeks)<br>2020-11-13 - Reconsider after revision<br>2020-11-13 - Unlocked<br>Note: Personal review recived<br>2020-11-13 - Review pending<br>2020-11-12 - Evaluation requests sent to reviewers<br>2020-10-20 - Review pending<br>2020-10-20 - Evaluation requests sent to reviewers<br>2020-10-19 - After scientific triage<br>2020-10-19 - In scientific triage<br>2020-10-19 - Manuscript accepted for processing<br>2020-10-18 - After plagiarism verification 2<br>2020-10-18 - Sent for plagiarism verification 2<br>2020-10-17 - Man corrected after CrossCheck<br>2020-10-12 - CrossChecked - returned to authors for reply<br>2020-10-12 - Manuscript CrossChecked<br>2020-10-12 - Sent for Plagiarism CrossCheck<br>2020-10-12 - Submission Approved<br>2020-10-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/706d98e903d948364dfbf8450a2a19a2/53c01bd4b72a019dc1a06e2f2e3a7dc9.jpg, createdBy=26e72333435, createdName=12275916m01(暂无昵称), createdTime=Mon Nov 30 08:53:39 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960021, encodeId=2e1996002110, content=review pending后又变成Evaluation requests sent to reviewers 这是什么鬼??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Sat Apr 24 14:00:56 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800814, encodeId=d44b80081440, content=自己的第一篇投稿,mark一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Jul 01 20:19:28 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911882, encodeId=a43991188243, content=请问一下:我的文章在2020.11-19 t投稿,到现在还是review pending状态,请问怎么回事。我可以催稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/15/13ad315b99d85311e6569c41e7ed47b6.jpg, createdBy=43f42415702, createdName=liuweihansbraun_24757598, createdTime=Tue Dec 29 12:30:21 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905404, encodeId=215e9054046f, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:走的普通通道,临床回顾性文章,9月14日投稿,11月初修回,12月3日直接接收,还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a01905698, createdName=ms4149556704004813, createdTime=Sun Dec 06 14:15:27 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131403, encodeId=ab252131403b8, content=偏重的研究方向:综合<br>经验分享:2023-05-09 Evaluation requests sent to reviewers 2023-05-02 Review pending 2023-05-02 Evaluation requests sent to reviewers 2023-04-25 Review pending 2023-04-25 Evaluation requests sent to reviewers 2023-04-17 Review pending 2023-04-11 Evaluation requests sent to reviewers 为什么我一个月内送了四次(evaluation request to reviewers+review pending),是文章问题还是审稿人少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bfd5550012, createdName=ms2000001057542904, createdTime=Wed May 10 14:55:41 CST 2023, time=2023-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省)]
    2020-12-29 liuweihansbraun_24757598

    请问一下:我的文章在2020.11-19 t投稿,到现在还是review pending状态,请问怎么回事。我可以催稿吗?

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=892175, encodeId=a5c48921e5f7, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:动脉硬化<br>经验分享:2500刀版面费。<br>2020-05-23 - Published<br>2020-03-28 - READY for publication<br>Note: Estimated Publication Date: May 24 - May 30, 2020<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Sent for prepublication antiplagiarism verification<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Proofread<br>2020-03-26 - Galley proof sent to authors<br>2020-03-16 - Sent for production<br>2020-03-16 - After copyediting<br>2020-03-15 - Waiting for authors decision after copyediting<br>2020-03-03 - In Copyediting<br>2020-03-03 - Paid<br>2020-03-02 - Accepted - invoice issued<br>2020-03-02 - After 1st post-review antiplagiarism verification<br>2020-03-02 - Sent for 1st post-review antiplagiarism verification<br>2020-03-02 - Ready for post-review antiplagiarism verification<br>2020-02-25 - Review 2 pending<br>2020-02-24 - Review 2 requests sent to reviewers<br>2020-02-23 - After authors corrections<br>2020-02-09 - Sent to author(s) for corrections (2 weeks)<br>2020-02-09 - Reconsider after revision<br>2020-02-07 - Awaiting decision<br>2020-02-07 - 2nd Scientific Triage Completed<br>2020-02-07 - In 2nd Scientific triage<br>2020-02-04 - Unlocked<br>2020-01-30 - Review pending<br>2020-01-30 - Evaluation requests sent to reviewers<br>2020-01-29 - After scientific triage<br>2020-01-29 - On hold<br>Note: Waiting for IRB translation.<br>2020-01-29 - In scientific triage<br>2020-01-29 - Manuscript accepted for processing<br>2020-01-29 - Manuscript CrossChecked<br>2020-01-29 - Sent for Plagiarism CrossCheck<br>2020-01-29 - Submission Approved<br>2020-01-29 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b642107106, createdName=阿桑v, createdTime=Thu Oct 15 09:07:26 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:医学<br>经验分享:一篇综述,从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见,有个六七条重复的,算大修吧,段落有调整,增加了部分内容和两个表格。逐条修改并回应审稿人,没用二次修改。共三次查重,投之前自己查了,修稿后自己也查了,所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591074, encodeId=a36a5910e45d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:看了这么多经验,中了也来回报一下大家。周期大致2个月左右。一般修稿感觉基本都有戏。 <br> 2020-05-06 - Accepted - invoice issued <br> 2020-05-06 - After 1st post-review antiplagiarism verification <br> 2020-05-06 - Sent for 1st post-review antiplagiarism verification <br> 2020-05-06 - Ready for post-review antiplagiarism verification <br> 2020-05-06 - Unlocked <br> Note: corrected <br> 2020-05-05 - On hold <br> Note: references should be in brackets [], and in line with the text [1] <br> 2020-05-05 - After authors corrections <br> 2020-04-20 - Sent to author for corrections (3 weeks) <br> 2020-04-20 - Reconsider after revision <br> 2020-04-19 - Awaiting decision <br> 2020-04-19 - 2nd Scientific Triage Completed <br> 2020-04-19 - In 2nd Scientific triage <br> 2020-04-01 - Review pending <br> 2020-03-17 - Evaluation requests sent to reviewers <br> 2020-03-01 - Unlocked <br> 2020-02-26 - Review pending <br> 2020-02-26 - Evaluation requests sent to reviewers <br> 2020-02-26 - On hold <br> Note: Waiting for IRB / IACUC <br> 2020-02-25 - After scientific triage <br> 2020-02-25 - In scientific triage <br> 2020-02-25 - Manuscript accepted for processing <br> 2020-02-25 - Manuscript CrossChecked <br> 2020-02-25 - Sent for Plagiarism CrossCheck <br> 2020-02-25 - Submission Approved <br> 2020-02-23 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24b12097035, createdName=1229603520_71901765, createdTime=Sun May 17 18:27:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903465, encodeId=3c0090346548, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:肿瘤临床研究;生物信息分析<br>经验分享:整体投稿,编辑处理,审稿效率超出我的预期,投稿到接收大概一个半月。<br><br>2020-11-29 - In Copyediting<br>2020-11-29 - Paid<br>2020-11-27 - Accepted - invoice issued<br>2020-11-27 - After 1st post-review antiplagiarism verification<br>2020-11-27 - Sent for 1st post-review antiplagiarism verification<br>2020-11-27 - Ready for post-review antiplagiarism verification<br>2020-11-26 - Review 2 pending<br>2020-11-26 - Review 2 requests sent to reviewers<br>2020-11-26 - After authors corrections<br>2020-11-13 - Sent to author(s) for corrections (2 weeks)<br>2020-11-13 - Reconsider after revision<br>2020-11-13 - Unlocked<br>Note: Personal review recived<br>2020-11-13 - Review pending<br>2020-11-12 - Evaluation requests sent to reviewers<br>2020-10-20 - Review pending<br>2020-10-20 - Evaluation requests sent to reviewers<br>2020-10-19 - After scientific triage<br>2020-10-19 - In scientific triage<br>2020-10-19 - Manuscript accepted for processing<br>2020-10-18 - After plagiarism verification 2<br>2020-10-18 - Sent for plagiarism verification 2<br>2020-10-17 - Man corrected after CrossCheck<br>2020-10-12 - CrossChecked - returned to authors for reply<br>2020-10-12 - Manuscript CrossChecked<br>2020-10-12 - Sent for Plagiarism CrossCheck<br>2020-10-12 - Submission Approved<br>2020-10-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/706d98e903d948364dfbf8450a2a19a2/53c01bd4b72a019dc1a06e2f2e3a7dc9.jpg, createdBy=26e72333435, createdName=12275916m01(暂无昵称), createdTime=Mon Nov 30 08:53:39 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960021, encodeId=2e1996002110, content=review pending后又变成Evaluation requests sent to reviewers 这是什么鬼??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Sat Apr 24 14:00:56 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800814, encodeId=d44b80081440, content=自己的第一篇投稿,mark一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Jul 01 20:19:28 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911882, encodeId=a43991188243, content=请问一下:我的文章在2020.11-19 t投稿,到现在还是review pending状态,请问怎么回事。我可以催稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/15/13ad315b99d85311e6569c41e7ed47b6.jpg, createdBy=43f42415702, createdName=liuweihansbraun_24757598, createdTime=Tue Dec 29 12:30:21 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905404, encodeId=215e9054046f, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:走的普通通道,临床回顾性文章,9月14日投稿,11月初修回,12月3日直接接收,还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a01905698, createdName=ms4149556704004813, createdTime=Sun Dec 06 14:15:27 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131403, encodeId=ab252131403b8, content=偏重的研究方向:综合<br>经验分享:2023-05-09 Evaluation requests sent to reviewers 2023-05-02 Review pending 2023-05-02 Evaluation requests sent to reviewers 2023-04-25 Review pending 2023-04-25 Evaluation requests sent to reviewers 2023-04-17 Review pending 2023-04-11 Evaluation requests sent to reviewers 为什么我一个月内送了四次(evaluation request to reviewers+review pending),是文章问题还是审稿人少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bfd5550012, createdName=ms2000001057542904, createdTime=Wed May 10 14:55:41 CST 2023, time=2023-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省)]
    2020-12-06 ms4149556704004813

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:走的普通通道,临床回顾性文章,9月14日投稿,11月初修回,12月3日直接接收,还行

    4

    展开4条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=892175, encodeId=a5c48921e5f7, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:动脉硬化<br>经验分享:2500刀版面费。<br>2020-05-23 - Published<br>2020-03-28 - READY for publication<br>Note: Estimated Publication Date: May 24 - May 30, 2020<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Sent for prepublication antiplagiarism verification<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Proofread<br>2020-03-26 - Galley proof sent to authors<br>2020-03-16 - Sent for production<br>2020-03-16 - After copyediting<br>2020-03-15 - Waiting for authors decision after copyediting<br>2020-03-03 - In Copyediting<br>2020-03-03 - Paid<br>2020-03-02 - Accepted - invoice issued<br>2020-03-02 - After 1st post-review antiplagiarism verification<br>2020-03-02 - Sent for 1st post-review antiplagiarism verification<br>2020-03-02 - Ready for post-review antiplagiarism verification<br>2020-02-25 - Review 2 pending<br>2020-02-24 - Review 2 requests sent to reviewers<br>2020-02-23 - After authors corrections<br>2020-02-09 - Sent to author(s) for corrections (2 weeks)<br>2020-02-09 - Reconsider after revision<br>2020-02-07 - Awaiting decision<br>2020-02-07 - 2nd Scientific Triage Completed<br>2020-02-07 - In 2nd Scientific triage<br>2020-02-04 - Unlocked<br>2020-01-30 - Review pending<br>2020-01-30 - Evaluation requests sent to reviewers<br>2020-01-29 - After scientific triage<br>2020-01-29 - On hold<br>Note: Waiting for IRB translation.<br>2020-01-29 - In scientific triage<br>2020-01-29 - Manuscript accepted for processing<br>2020-01-29 - Manuscript CrossChecked<br>2020-01-29 - Sent for Plagiarism CrossCheck<br>2020-01-29 - Submission Approved<br>2020-01-29 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b642107106, createdName=阿桑v, createdTime=Thu Oct 15 09:07:26 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:医学<br>经验分享:一篇综述,从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见,有个六七条重复的,算大修吧,段落有调整,增加了部分内容和两个表格。逐条修改并回应审稿人,没用二次修改。共三次查重,投之前自己查了,修稿后自己也查了,所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591074, encodeId=a36a5910e45d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:看了这么多经验,中了也来回报一下大家。周期大致2个月左右。一般修稿感觉基本都有戏。 <br> 2020-05-06 - Accepted - invoice issued <br> 2020-05-06 - After 1st post-review antiplagiarism verification <br> 2020-05-06 - Sent for 1st post-review antiplagiarism verification <br> 2020-05-06 - Ready for post-review antiplagiarism verification <br> 2020-05-06 - Unlocked <br> Note: corrected <br> 2020-05-05 - On hold <br> Note: references should be in brackets [], and in line with the text [1] <br> 2020-05-05 - After authors corrections <br> 2020-04-20 - Sent to author for corrections (3 weeks) <br> 2020-04-20 - Reconsider after revision <br> 2020-04-19 - Awaiting decision <br> 2020-04-19 - 2nd Scientific Triage Completed <br> 2020-04-19 - In 2nd Scientific triage <br> 2020-04-01 - Review pending <br> 2020-03-17 - Evaluation requests sent to reviewers <br> 2020-03-01 - Unlocked <br> 2020-02-26 - Review pending <br> 2020-02-26 - Evaluation requests sent to reviewers <br> 2020-02-26 - On hold <br> Note: Waiting for IRB / IACUC <br> 2020-02-25 - After scientific triage <br> 2020-02-25 - In scientific triage <br> 2020-02-25 - Manuscript accepted for processing <br> 2020-02-25 - Manuscript CrossChecked <br> 2020-02-25 - Sent for Plagiarism CrossCheck <br> 2020-02-25 - Submission Approved <br> 2020-02-23 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24b12097035, createdName=1229603520_71901765, createdTime=Sun May 17 18:27:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903465, encodeId=3c0090346548, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:肿瘤临床研究;生物信息分析<br>经验分享:整体投稿,编辑处理,审稿效率超出我的预期,投稿到接收大概一个半月。<br><br>2020-11-29 - In Copyediting<br>2020-11-29 - Paid<br>2020-11-27 - Accepted - invoice issued<br>2020-11-27 - After 1st post-review antiplagiarism verification<br>2020-11-27 - Sent for 1st post-review antiplagiarism verification<br>2020-11-27 - Ready for post-review antiplagiarism verification<br>2020-11-26 - Review 2 pending<br>2020-11-26 - Review 2 requests sent to reviewers<br>2020-11-26 - After authors corrections<br>2020-11-13 - Sent to author(s) for corrections (2 weeks)<br>2020-11-13 - Reconsider after revision<br>2020-11-13 - Unlocked<br>Note: Personal review recived<br>2020-11-13 - Review pending<br>2020-11-12 - Evaluation requests sent to reviewers<br>2020-10-20 - Review pending<br>2020-10-20 - Evaluation requests sent to reviewers<br>2020-10-19 - After scientific triage<br>2020-10-19 - In scientific triage<br>2020-10-19 - Manuscript accepted for processing<br>2020-10-18 - After plagiarism verification 2<br>2020-10-18 - Sent for plagiarism verification 2<br>2020-10-17 - Man corrected after CrossCheck<br>2020-10-12 - CrossChecked - returned to authors for reply<br>2020-10-12 - Manuscript CrossChecked<br>2020-10-12 - Sent for Plagiarism CrossCheck<br>2020-10-12 - Submission Approved<br>2020-10-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/706d98e903d948364dfbf8450a2a19a2/53c01bd4b72a019dc1a06e2f2e3a7dc9.jpg, createdBy=26e72333435, createdName=12275916m01(暂无昵称), createdTime=Mon Nov 30 08:53:39 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960021, encodeId=2e1996002110, content=review pending后又变成Evaluation requests sent to reviewers 这是什么鬼??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Sat Apr 24 14:00:56 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800814, encodeId=d44b80081440, content=自己的第一篇投稿,mark一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Jul 01 20:19:28 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911882, encodeId=a43991188243, content=请问一下:我的文章在2020.11-19 t投稿,到现在还是review pending状态,请问怎么回事。我可以催稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/15/13ad315b99d85311e6569c41e7ed47b6.jpg, createdBy=43f42415702, createdName=liuweihansbraun_24757598, createdTime=Tue Dec 29 12:30:21 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905404, encodeId=215e9054046f, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:走的普通通道,临床回顾性文章,9月14日投稿,11月初修回,12月3日直接接收,还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a01905698, createdName=ms4149556704004813, createdTime=Sun Dec 06 14:15:27 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131403, encodeId=ab252131403b8, content=偏重的研究方向:综合<br>经验分享:2023-05-09 Evaluation requests sent to reviewers 2023-05-02 Review pending 2023-05-02 Evaluation requests sent to reviewers 2023-04-25 Review pending 2023-04-25 Evaluation requests sent to reviewers 2023-04-17 Review pending 2023-04-11 Evaluation requests sent to reviewers 为什么我一个月内送了四次(evaluation request to reviewers+review pending),是文章问题还是审稿人少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bfd5550012, createdName=ms2000001057542904, createdTime=Wed May 10 14:55:41 CST 2023, time=2023-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省)]
    2023-05-10 ms2000001057542904 来自广东省

    偏重的研究方向:综合
    经验分享:2023-05-09 Evaluation requests sent to reviewers 2023-05-02 Review pending 2023-05-02 Evaluation requests sent to reviewers 2023-04-25 Review pending 2023-04-25 Evaluation requests sent to reviewers 2023-04-17 Review pending 2023-04-11 Evaluation requests sent to reviewers 为什么我一个月内送了四次(evaluation request to reviewers+review pending),是文章问题还是审稿人少

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=892175, encodeId=a5c48921e5f7, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:动脉硬化<br>经验分享:2500刀版面费。<br>2020-05-23 - Published<br>2020-03-28 - READY for publication<br>Note: Estimated Publication Date: May 24 - May 30, 2020<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Sent for prepublication antiplagiarism verification<br>2020-03-28 - Ready for prepublication antiplagiarism verification<br>2020-03-28 - Proofread<br>2020-03-26 - Galley proof sent to authors<br>2020-03-16 - Sent for production<br>2020-03-16 - After copyediting<br>2020-03-15 - Waiting for authors decision after copyediting<br>2020-03-03 - In Copyediting<br>2020-03-03 - Paid<br>2020-03-02 - Accepted - invoice issued<br>2020-03-02 - After 1st post-review antiplagiarism verification<br>2020-03-02 - Sent for 1st post-review antiplagiarism verification<br>2020-03-02 - Ready for post-review antiplagiarism verification<br>2020-02-25 - Review 2 pending<br>2020-02-24 - Review 2 requests sent to reviewers<br>2020-02-23 - After authors corrections<br>2020-02-09 - Sent to author(s) for corrections (2 weeks)<br>2020-02-09 - Reconsider after revision<br>2020-02-07 - Awaiting decision<br>2020-02-07 - 2nd Scientific Triage Completed<br>2020-02-07 - In 2nd Scientific triage<br>2020-02-04 - Unlocked<br>2020-01-30 - Review pending<br>2020-01-30 - Evaluation requests sent to reviewers<br>2020-01-29 - After scientific triage<br>2020-01-29 - On hold<br>Note: Waiting for IRB translation.<br>2020-01-29 - In scientific triage<br>2020-01-29 - Manuscript accepted for processing<br>2020-01-29 - Manuscript CrossChecked<br>2020-01-29 - Sent for Plagiarism CrossCheck<br>2020-01-29 - Submission Approved<br>2020-01-29 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b642107106, createdName=阿桑v, createdTime=Thu Oct 15 09:07:26 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242888, encodeId=d7e7124288847, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:医学<br>经验分享:一篇综述,从投到要发表共四个月零几天。等待外审时间较长。外审一共给了三十条意见,有个六七条重复的,算大修吧,段落有调整,增加了部分内容和两个表格。逐条修改并回应审稿人,没用二次修改。共三次查重,投之前自己查了,修稿后自己也查了,所以不涉及重复率高的问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11df8096943, createdName=望洋兴叹0, createdTime=Sat Sep 03 00:08:29 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591074, encodeId=a36a5910e45d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:看了这么多经验,中了也来回报一下大家。周期大致2个月左右。一般修稿感觉基本都有戏。 <br> 2020-05-06 - Accepted - invoice issued <br> 2020-05-06 - After 1st post-review antiplagiarism verification <br> 2020-05-06 - Sent for 1st post-review antiplagiarism verification <br> 2020-05-06 - Ready for post-review antiplagiarism verification <br> 2020-05-06 - Unlocked <br> Note: corrected <br> 2020-05-05 - On hold <br> Note: references should be in brackets [], and in line with the text [1] <br> 2020-05-05 - After authors corrections <br> 2020-04-20 - Sent to author for corrections (3 weeks) <br> 2020-04-20 - Reconsider after revision <br> 2020-04-19 - Awaiting decision <br> 2020-04-19 - 2nd Scientific Triage Completed <br> 2020-04-19 - In 2nd Scientific triage <br> 2020-04-01 - Review pending <br> 2020-03-17 - Evaluation requests sent to reviewers <br> 2020-03-01 - Unlocked <br> 2020-02-26 - Review pending <br> 2020-02-26 - Evaluation requests sent to reviewers <br> 2020-02-26 - On hold <br> Note: Waiting for IRB / IACUC <br> 2020-02-25 - After scientific triage <br> 2020-02-25 - In scientific triage <br> 2020-02-25 - Manuscript accepted for processing <br> 2020-02-25 - Manuscript CrossChecked <br> 2020-02-25 - Sent for Plagiarism CrossCheck <br> 2020-02-25 - Submission Approved <br> 2020-02-23 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24b12097035, createdName=1229603520_71901765, createdTime=Sun May 17 18:27:00 CST 2020, time=2020-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903465, encodeId=3c0090346548, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0<br>偏重的研究方向:肿瘤临床研究;生物信息分析<br>经验分享:整体投稿,编辑处理,审稿效率超出我的预期,投稿到接收大概一个半月。<br><br>2020-11-29 - In Copyediting<br>2020-11-29 - Paid<br>2020-11-27 - Accepted - invoice issued<br>2020-11-27 - After 1st post-review antiplagiarism verification<br>2020-11-27 - Sent for 1st post-review antiplagiarism verification<br>2020-11-27 - Ready for post-review antiplagiarism verification<br>2020-11-26 - Review 2 pending<br>2020-11-26 - Review 2 requests sent to reviewers<br>2020-11-26 - After authors corrections<br>2020-11-13 - Sent to author(s) for corrections (2 weeks)<br>2020-11-13 - Reconsider after revision<br>2020-11-13 - Unlocked<br>Note: Personal review recived<br>2020-11-13 - Review pending<br>2020-11-12 - Evaluation requests sent to reviewers<br>2020-10-20 - Review pending<br>2020-10-20 - Evaluation requests sent to reviewers<br>2020-10-19 - After scientific triage<br>2020-10-19 - In scientific triage<br>2020-10-19 - Manuscript accepted for processing<br>2020-10-18 - After plagiarism verification 2<br>2020-10-18 - Sent for plagiarism verification 2<br>2020-10-17 - Man corrected after CrossCheck<br>2020-10-12 - CrossChecked - returned to authors for reply<br>2020-10-12 - Manuscript CrossChecked<br>2020-10-12 - Sent for Plagiarism CrossCheck<br>2020-10-12 - Submission Approved<br>2020-10-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=165, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/706d98e903d948364dfbf8450a2a19a2/53c01bd4b72a019dc1a06e2f2e3a7dc9.jpg, createdBy=26e72333435, createdName=12275916m01(暂无昵称), createdTime=Mon Nov 30 08:53:39 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960021, encodeId=2e1996002110, content=review pending后又变成Evaluation requests sent to reviewers 这是什么鬼??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ad95447046, createdName=ms1000000289565013, createdTime=Sat Apr 24 14:00:56 CST 2021, time=2021-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800814, encodeId=d44b80081440, content=自己的第一篇投稿,mark一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=654c5395127, createdName=starter2009, createdTime=Wed Jul 01 20:19:28 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911882, encodeId=a43991188243, content=请问一下:我的文章在2020.11-19 t投稿,到现在还是review pending状态,请问怎么回事。我可以催稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/15/13ad315b99d85311e6569c41e7ed47b6.jpg, createdBy=43f42415702, createdName=liuweihansbraun_24757598, createdTime=Tue Dec 29 12:30:21 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905404, encodeId=215e9054046f, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:走的普通通道,临床回顾性文章,9月14日投稿,11月初修回,12月3日直接接收,还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6a01905698, createdName=ms4149556704004813, createdTime=Sun Dec 06 14:15:27 CST 2020, time=2020-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131403, encodeId=ab252131403b8, content=偏重的研究方向:综合<br>经验分享:2023-05-09 Evaluation requests sent to reviewers 2023-05-02 Review pending 2023-05-02 Evaluation requests sent to reviewers 2023-04-25 Review pending 2023-04-25 Evaluation requests sent to reviewers 2023-04-17 Review pending 2023-04-11 Evaluation requests sent to reviewers 为什么我一个月内送了四次(evaluation request to reviewers+review pending),是文章问题还是审稿人少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bfd5550012, createdName=ms2000001057542904, createdTime=Wed May 10 14:55:41 CST 2023, time=2023-05-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2110952, encodeId=2a9e2110952d8, content=这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIOxGicybXibtrPQz1cYBuXpKbicRbxmZbkKPJNTyJT6L89MjNezRXCIoeN9fwnTTzdfpWc7Ino0h6IQ/132, createdBy=401a2450840, createdName=ms9354616365725748, createdTime=Fri Jan 20 08:59:17 CST 2023, time=2023-01-20, status=1, ipAttribution=江苏省)]
    2023-01-20 ms9354616365725748 来自江苏省

    这个黑心杂志,给我寄来接收函,版面费都交了,过了几天又给拒了,TMD可气的是钱一直不退给我,都两年了,一直推诿

    3

    展开3条回复
共500条页码: 3/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分